Furthermore, findings from the EBCTCG overview [13] in 1998 showed a greater proportional reduction in BC recurrence and mortality in women who had high ER concentrations (at least 100 fmol per mg cytosol protein) in the tumor compared with women who had tumors with lower ER. The gene discussed is ESR1; the disease is breast cancer.